# Neos Therapeutics, Inc.

Neos Therapeutics, Inc. is a company headquartered in Grand Prairie, TX, United States.

## Company overview

- **Legal name:** Neos Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Grand Prairie, TX, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001467652

## About

Neos Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001467652, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-13, it reported annual revenue of USD 64,649,000; net income of USD -16,902,000; total assets of USD 90,873,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $64.6M (USD 64,649,000)
- **Net income:** -$16.9M (USD -16,902,000)
- **Total assets:** $90.9M (USD 90,873,000)
- **Cash and equivalents:** $16.8M (USD 16,830,000)
- **Operating cash flow:** -$10.8M (USD -10,783,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $50.0M (USD 49,988,000)
- **Net income:** -$51.7M (USD -51,675,000)
- **Total assets:** $111.4M (USD 111,357,000)
- **Cash and equivalents:** $46.5M (USD 46,478,000)
- **Operating cash flow:** -$41.4M (USD -41,441,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2017 (period ended 2017-12-31)

- **Net income:** -$66.2M (USD -66,247,000)
- **Total assets:** $107.4M (USD 107,353,000)
- **Cash and equivalents:** $32.0M (USD 31,969,000)
- **Operating cash flow:** -$53.3M (USD -53,261,000)
- **Later filings:** Net income, Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $9.2M (USD 9,154,000)
- **Net income:** -$83.3M (USD -83,333,000)
- **Total assets:** $80.1M (USD 80,142,000)
- **Cash and equivalents:** $24.4M (USD 24,352,000)
- **Later filings:** Net income, Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2021-03-22 — period 2021-03-18 — CURRENT REPORT
- Form 8-K — filed 2021-02-08 — period 2021-02-05 — 8-K
- Form 8-K — filed 2021-01-11 — period 2021-01-11 — FORM 8-K
- Form 8-K — filed 2020-12-30 — period 2020-12-29 — 8-K
- Form 8-K — filed 2020-12-11 — period 2020-12-10 — FORM 8-K
- Form 8-K — filed 2020-12-10 — period 2020-12-10 — FORM 8-K
- Form 10-Q — filed 2020-11-09 — period 2020-09-30 — 10-Q
- Form 8-K — filed 2020-11-09 — period 2020-11-09 — 8-K
- Form 10-Q — filed 2020-08-10 — period 2020-06-30 — 10-Q
- Form 8-K — filed 2020-08-10 — period 2020-08-10 — 8-K
- Form 8-K — filed 2020-06-19 — period 2020-06-18 — 8-K
- Form 8-K — filed 2020-06-11 — period 2020-06-10 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/neos-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology